Showing results (1161-1170 of 1,963) with videos related to

Sort By:
Pageof 197
RMD Open|May 13, 2020
Assessing the sensitivity to change of the OMERACT ultrasound structural gout lesions during urate-lowering therapySara Nysom Christiansen, Mikkel Østergaard, Ole Slot, et al.
RMD Open|May 7, 2020
Long-term safety, immunogenicity and efficacy comparing FKB327 with the adalimumab reference product in patients with active rheumatoid arthritis: data from randomised double-blind and open-label extension studiesMark C Genovese, Herbert Kellner, Yasumasa Arai, et al.
RMD Open|June 23, 2020
Atlas of the OMERACT Heel Enthesitis MRI Scoring System (HEMRIS)Ashish J Mathew, Simon Krabbe, Iris Eshed, et al.
RMD Open|May 20, 2020
Siblings of patients with rheumatoid arthritis have an increased mortality rate: a Swedish cohort studyHelga Westerlind, Bénédicte Delcoigne, Johan Askling
RMD Open|May 10, 2020
Peripheral spondyloarthritis: a neglected entity-state of the artPhilippe Carron, Ann-Sophie De Craemer, Filip Van den Bosch
RMD Open|January 4, 2023
Long-term follow-up of certolizumab pegol in uveitis due to immune-mediated inflammatory diseases: multicentre study of 80 patientsJosé Luis Martín-Varillas, Lara Sanchez-Bilbao, Vanesa Calvo-Río, et al.
RMD Open|January 4, 2023
Fluorescence-optical imaging as a promising easy-to-use imaging biomarker to increase early psoriatic arthritis detection in patients with psoriasis: a cross-sectional cohort study with follow-upMichaela Koehm, Sarah Ohrndorf, Ann C Foldenauer, et al.
RMD Open|January 4, 2023
Prediction of response to anti-TNF treatment using laboratory biomarkers in patients with rheumatoid arthritis: a systematic reviewMaike H M Wientjes, Alfons A den Broeder, Paco M J Welsing, et al.
RMD Open|January 4, 2023
Long-term persistence of second-line biologics in psoriatic arthritis patients with prior TNF inhibitor exposure: a nationwide cohort study from the French health insurance database (SNDS)Laura Pina Vegas, Léa Hoisnard, Léa Bastard, et al.
RMD Open|January 4, 2023
Tapering glucocorticoids and risk of flare in rheumatoid arthritis on biological disease-modifying antirheumatic drugs (bDMARDs)Giovanni Adami, Angelo Fassio, Maurizio Rossini, et al.
Pageof 197